367 related articles for article (PubMed ID: 9138434)
21. Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.
Leysen JE; Gommeren W; Van Gompel P; Wynants J; Janssen PF; Laduron PM
Mol Pharmacol; 1985 Jun; 27(6):600-11. PubMed ID: 2860558
[TBL] [Abstract][Full Text] [Related]
22. Effect of chronic serotonin-2 receptor agonist or antagonist administration on serotonin-1A receptor sensitivity.
Hensler JG; Truett KA
Neuropsychopharmacology; 1998 Nov; 19(5):354-64. PubMed ID: 9778658
[TBL] [Abstract][Full Text] [Related]
23. Effects of novel antipsychotics with mixed D(2) antagonist/5-HT(1A) agonist properties on PCP-induced social interaction deficits in the rat.
Bruins Slot LA; Kleven MS; Newman-Tancredi A
Neuropharmacology; 2005 Dec; 49(7):996-1006. PubMed ID: 16009387
[TBL] [Abstract][Full Text] [Related]
24. Investigation of mixed D2/5-HT1A activity of N-heteroarylmethyl-N-phenylpiperazines, N-heteroarylethyl-N-phenylpiperazines and N-heteroarylpropyl-N-phenylpiperazines.
Roglić G; Dukić-Stefanović S; Andrić D; Kostić-Rajacić S; Soskić V
Pharmazie; 2001 Oct; 56(10):803-7. PubMed ID: 11683128
[TBL] [Abstract][Full Text] [Related]
25. D2 but not D3 receptors are elevated after 9 or 11 months chronic haloperidol treatment: influence of withdrawal period.
Joyce JN
Synapse; 2001 May; 40(2):137-44. PubMed ID: 11252025
[TBL] [Abstract][Full Text] [Related]
26. Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain1.
Kulikov A; Moreau X; Jeanningros R
Neuroendocrinology; 1999 Jun; 69(6):453-9. PubMed ID: 10364698
[TBL] [Abstract][Full Text] [Related]
27. 9-substituted 1,2,3,4-tetrahydro-beta-carbolin-1-ones, new 5-HT1A and 5-HT2A receptor ligands.
Mokrosz MJ; Boksa J; Charakchieva-Minol S; Wesołowska A; Borycz J
Pol J Pharmacol; 1999; 51(4):351-6. PubMed ID: 10540967
[TBL] [Abstract][Full Text] [Related]
28. Serotonin and learned helplessness: a regional study of 5-HT1A, 5-HT2A receptors and the serotonin transport site in rat brain.
Wu J; Kramer GL; Kram M; Steciuk M; Crawford IL; Petty F
J Psychiatr Res; 1999; 33(1):17-22. PubMed ID: 10094235
[TBL] [Abstract][Full Text] [Related]
29. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
Oz M; Zhang L; Rotondo A; Sun H; Morales M
Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
[TBL] [Abstract][Full Text] [Related]
30. 5-HT6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus.
Li Z; Huang M; Prus AJ; Dai J; Meltzer HY
Brain Res; 2007 Feb; 1134(1):70-8. PubMed ID: 17207474
[TBL] [Abstract][Full Text] [Related]
31. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone.
Zhang L; Ma W; Barker JL; Rubinow DR
Neuroscience; 1999; 94(1):251-9. PubMed ID: 10613515
[TBL] [Abstract][Full Text] [Related]
32. Effects of ritanserin on haloperidol-induced dopamine (D2) receptor up-regulation in the rat.
Szczepanik AM; Wilmot CA
Neurosci Lett; 1997 Aug; 231(2):91-4. PubMed ID: 9291148
[TBL] [Abstract][Full Text] [Related]
33. Effects of donepezil, nicotine and haloperidol on the central serotonergic system in mice: implications for Tourette's syndrome.
Hayslett RL; Tizabi Y
Pharmacol Biochem Behav; 2005 Aug; 81(4):879-86. PubMed ID: 16045972
[TBL] [Abstract][Full Text] [Related]
34. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
[TBL] [Abstract][Full Text] [Related]
35. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
36. 5-HT1A-versus D2-receptor selectivity of flesinoxan and analogous N4-substituted N1-arylpiperazines.
Kuipers W; Kruse CG; van Wijngaarden I; Standaar PJ; Tulp MT; Veldman N; Spek AL; IJzerman AP
J Med Chem; 1997 Jan; 40(3):300-12. PubMed ID: 9022796
[TBL] [Abstract][Full Text] [Related]
37. MP-3022, a new putative antagonist at pre- and postsynaptic 5-HT1A receptors.
Przegaliński E; Filip M; Bijak M; Wedzony K; Budziszewska B; Tokarski K; Maćkowiak M; Fijał K
Pol J Pharmacol; 1996; 48(1):13-22. PubMed ID: 9112623
[TBL] [Abstract][Full Text] [Related]
38. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
[TBL] [Abstract][Full Text] [Related]
39. Effect of chronic haloperidol treatment on dopamine-induced inositol phosphate formation in rat brain slices.
Li R; Chuang DM; Wyatt RJ; Kirch DG
Neurochem Res; 1994 Jun; 19(6):673-8. PubMed ID: 8065524
[TBL] [Abstract][Full Text] [Related]
40. The effect of chronic treatment with a novel aryl-piperazine antipsychotic on monoamine receptors in rat brain.
Shapiro LA; Offord SJ; Ordway GA
Brain Res; 1995 Apr; 677(2):250-6. PubMed ID: 7552250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
